Low endotoxin release from Escherichia coli and Bacteroides fragilis during exposure to moxifloxacin.

Abstract:

BACKGROUND:Bacterial endotoxin is known to act as a potent trigger of disseminated coagulation and septic shock. During clinical antibiotic treatment, endotoxin may be released from Gram-negative bacteria. It is known that antibiotic classes differ in their ability to induce endotoxin release. AIM:It was the aim of this study to test the endotoxin-liberating potential of different antibiotics with activity against Escherichia coli and Bacteroides fragilis. METHODS:In vitro test models were used to evaluate the endotoxin-liberating potential of moxifloxacin, a 4th-generation quinolone with antianaerobic activity. Bacteria were exposed to moxifloxacin at 2×, 10× and 50× the minimal inhibitory concentration. Endotoxin release was measured by enzyme-linked immunosorbent and Limulus amoebocyte lysate assays. Comparator drugs were ceftazidime and imipenem, i.e. antibiotics with known high and low endotoxin-liberating potential, respectively. As a parameter for biological responses to endotoxin, the release of proinflammatory cytokines (tumor necrosis factor-α, interleukin-1β) from monocytes/macrophages was quantified with bioassays. RESULTS:In all test systems, release of endotoxin during exposure of bacteria to moxifloxacin was minimal or low and comparable with that of imipenem. CONCLUSIONS:Moxifloxacin has a low potential to cause endotoxin-mediated detrimental clinical effects. Concerning its endotoxin-releasing properties, moxifloxacin appears to be a choice equivalent to the carbapenems.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Trautmann M,Scheibe C,Wellinghausen N,Holst O,Lepper PM

doi

10.1159/000321622

subject

Has Abstract

pub_date

2010-01-01 00:00:00

pages

364-70

issue

5

eissn

0009-3157

issn

1421-9794

pii

000321622

journal_volume

56

pub_type

杂志文章
  • Tapering and discontinuation of glucocorticoid prophylaxis during prolonged weekly to biweekly paclitaxel administration.

    abstract:BACKGROUND:Taxanes cause hypersensitivity reactions, averted by premedication with H1 blockers and high glucocorticoid (GC) doses. Prolonged weekly taxane administration may lead to GC toxicity. PURPOSE:To determine whether patients not hypersensitive to initial paclitaxel (PTX) infusion after high-dose GC premedicati...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000085618

    authors: Braverman AS,Rao S,Salvatti ME,Adamson B,McManus M,Pierre S

    更新日期:2005-05-01 00:00:00

  • Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model.

    abstract:BACKGROUND:The efficacy of fluconazole (FLU), amphotericin B (AMB) and caspofungin (CAS) was tested against three Candida orthopsilosis, three C. metapsilosis and two C. parapsilosis sensu stricto isolates in neutropenic mice. METHODS:Mice were immunosuppressed by 200 mg/kg cyclophosphamide. Five-day intraperitoneal t...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000337088

    authors: Szilágyi J,Földi R,Gesztelyi R,Bayegan S,Kardos G,Juhász B,Majoros L

    更新日期:2012-01-01 00:00:00

  • Studies on the antitumour effects of N-137.

    abstract::The antitumour properties of the drug N-137 were assessed in vivo in two murine T lymphoma models and two naturally metastatic hamster fibrosarcomas of Herpesvirus hominis aetiology. N-137 therapy caused a significant delay in the subcutaneous growth rate of both lymphomas (EL4 and TLX9) and in many cases completely p...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238091

    authors: Rees RC,Potter CW,Clegg A,Hall JM

    更新日期:1982-01-01 00:00:00

  • Feasibility study of adjuvant chemotherapy of S-1 and carboplatin for completely resected non-small cell lung cancer.

    abstract:BACKGROUND:The purpose of this study was to evaluate the feasibility and compliance of adjuvant chemotherapy of S-1 plus carboplatin for patients with completely resected non-small cell lung cancer (NSCLC) of pathological stage IB-IIIB. METHODS:S-1 was given orally at a dose of 80 mg/m²/day for 2 weeks, followed by a ...

    journal_title:Chemotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1159/000351101

    authors: Komazaki Y,Sakashita H,Furuiye M,Fujie T,Tamaoka M,Sumi Y,Miyazaki Y,Kojima K,Jin Y,Inase N

    更新日期:2013-01-01 00:00:00

  • Antitumor Efficacy of Combination Therapy Consisting of S-1, Leucovorin, and Oxaliplatin against Human Gastric Cancer Xenografts.

    abstract:BACKGROUND/AIM:A phase 3 trial of S-1, leucovorin (LV), and oxaliplatin for treating gastric cancer is now underway. However, the antitumor efficacy of the combination has not yet been examined in an in vivo preclinical study. This study examined the antitumor efficacy of combination therapy consisting of S-1, LV, and ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000486029

    authors: Nagase H,Nakagawa F,Uchida J

    更新日期:2018-01-01 00:00:00

  • Simple combined agar-strip test for detection of enterococcal susceptibility to ampicillin, moderate- or high-level gentamicin resistance and potential additive activity of ampicillin plus gentamicin.

    abstract::A simple combined agar-strip test (CAST), involving filter paper strips charged with 20 micrograms of ampicillin or 40 micrograms of gentamicin, accurately detected high-level gentamicin resistance among 43 of 146 isolates of Enterococcus faecalis and additive activity of ampicillin plus gentamicin against 101 of 103 ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239107

    authors: Traub WH,Leonhard B

    更新日期:1993-03-01 00:00:00

  • Therapeutic activity of pretazettine on Ehrlich ascites carcinoma: adjuvant effect on standard drugs in ABC regimen.

    abstract::A narcissus alkaloid, pretazettine hydrochloride (PTZ), has been shown to be active against Ehrlich ascites carcinoma. The Ehrlich cells are more sensitive to PTZ in DBA/2 mice than in Swiss mice. The therapeutic activity of the individual standard drugs in ABC (adriamycin, BCNU, and cyclophosphamide) regimen against ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237992

    authors: Furusawa E,Lum MK,Furusawa S

    更新日期:1981-01-01 00:00:00

  • Phase II trial of XELOX as first-line treatment for patients with advanced gastric cancer.

    abstract:BACKGROUND:The prognosis of patients with advanced gastric cancer (AGC) remains poor, and no single chemotherapy regimen is recognized as a global standard. A phase II trial was conducted to determine the efficacy and tolerability of capecitabine and oxaliplatin (XELOX) given every 3 weeks in combination in patients wi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000305256

    authors: Luo HY,Xu RH,Wang F,Qiu MZ,Li YH,Li FH,Zhou ZW,Chen XQ

    更新日期:2010-01-01 00:00:00

  • The clinical use of aztreonam.

    abstract::Aztreonam is the first monobactam antibiotic to be used clinically. It is highly resistant to beta-lactamases, and although its activity spectrum is similar to that of the aminoglycoside antibiotics, it has no effect on gram-positive bacteria. The current study was undertaken to determine the efficacy of aztreonam in ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238720

    authors: Schönwald S,Schoss-Vidensek Z,Car V,Krznar B

    更新日期:1989-01-01 00:00:00

  • New aspects of copper and iron metabolism in the myelodysplastic syndromes.

    abstract:BACKGROUND:Myelodysplastic syndrome (MDS) is an iron overload condition. Copper deficiency itself might induce dysplastic changes and iron overload. The relationship between the iron and copper metabolism is analyzed in MDS patients. METHODS:Copper, iron and ceruloplasmin levels were established, and transferrin satur...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000091307

    authors: Várkonyi J,Szabó T,Sebestyén P,Tordai A,Andrikovics H,Kollai G,Karádi I

    更新日期:2006-01-01 00:00:00

  • A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells.

    abstract::An in vitro infection model was created using a suspension of macrophages, polymorphonuclear leukocytes, lymphocytes, fibroblasts, and human serum to which pathogen and antibiotic were added. Separate intracellular and extracellular antibiotic concentrations and activity against Staphylococcus aureus and Legionella pn...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238987

    authors: Scaglione F,Demartini G,Dugnani S,Fraschini F

    更新日期:1993-11-01 00:00:00

  • Activity assays of thiadiazine derivatives on Trichomonas vaginalis and amastigote forms of Trypanosoma cruzi.

    abstract::Eight thiadiazine 1,1-dioxide derivatives were evaluated for antitrichomonal and antitrypanosomal activities. In vivo tests were performed on a murine model for trichomoniasis standardized in our laboratory. The capacity of compounds to clear visceral lesions in experimentally infected animals as well as their effects...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239040

    authors: Atienza J,Martínez Díaz RA,Gómez Barrio A,Escario JA,Herrero A,Ochoa C,Rodríguez J

    更新日期:1992-01-01 00:00:00

  • In vitro interactions of amikacin and beta-lactam antibiotics against amikacin-resistant gram-negative bacilli.

    abstract::We tested 42 strains of amikacin-resistant gram-negative bacilli with amikacin in combination with six beta-lactam antibiotics using the checkerboard and time-kill curve techniques. Synergism was demonstrated with time-killing curve in 43-68% of the strains tested. Ceftazidime plus amikacin was the most active combina...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238556

    authors: Alvarez S,Jones M,Holtsclaw-Berk S,Berk SL

    更新日期:1988-01-01 00:00:00

  • In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid).

    abstract::The in vitro activities of quinupristin/dalfopristin (Synercid), ampicillin, erythromycin, clarithromycin, vancomycin, teicoplanin, ciprofloxacin and tetracycline were examined and compared against 526 gram-positive bacteria. The minimal inhibitory concentrations (MICs) for quinupristin/dalfopristin against Staphyloco...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000048530

    authors: Ling TK,Fung KS,Cheng AF

    更新日期:2001-07-01 00:00:00

  • Changes of surface hydrophobicity and charge of Staphylococcus aureus treated with sub-MIC of antibiotics and their effects on the chemiluminescence response of phagocytic cells.

    abstract::The effects of the sub-MIC of antibiotics on the surface hydrophobicity and charge of Staphylococcus aureus were examined by the contact angle method and by microscopic electrophoresis, and the production of oxygen-derived radicals by mouse peritoneal macrophages was measured by a luminol-chemiluminescence assay. The ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239327

    authors: Nomura S,Kuroiwa A,Nagayama A

    更新日期:1995-03-01 00:00:00

  • Effect of hydrocortisone and BCNU on long-term murine bone marrow cultures.

    abstract::Hydrocortisone (HC) has been observed to influence an in vitro Dexter culture system with maintenance of pluripotent hematopoietic stem cells (CFU-s) and progenitor cells (CFU-gm, BFU-e). In the present study, a two-phase murine Dexter culture system was established to study the mechanism of HC-mediated suppression of...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238340

    authors: Horikoshi A,Murphy MJ Jr

    更新日期:1985-01-01 00:00:00

  • Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.

    abstract::The introduction of highly active antiretroviral therapy (HAART) has significantly modified the course of human immunodeficiency virus (HIV) disease, with longer survival and improved quality of life of HIV-infected subjects. However, HAART regimens, especially those including protease inhibitors, have been shown to c...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000093034

    authors: Barbaro G,Barbarini G

    更新日期:2006-01-01 00:00:00

  • Lack of effect of gemifloxacin on the steady-state pharmacodynamics of warfarin in healthy volunteers.

    abstract::Gemifloxacin is a novel fluoroquinolone with a broad spectrum of activity. This double-blind, randomized, parallel-group study was designed to demonstrate the lack of effect of steady-state concentrations of gemifloxacin on the pharmacodynamic effects of warfarin. Healthy male subjects received loading doses of warfar...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000007243

    authors: Davy M,Bird N,Rost KL,Fuder H

    更新日期:1999-11-01 00:00:00

  • Pharmacokinetic study on adenomatous prostate tissue concentrations of cefoperazone. Clinical efficacy and patient tolerance of intramuscular cefoperazone treatment of chronic bacterial prostatitis.

    abstract::Cephalosporins do not reach active therapeutical concentrations in the prostatic tissue in patients suffering from chronic bacterial prostatitis. Cefoperazone is an exception. Its efficacy in the treatment of chronic bacterial prostatitis in 20 patients was studied and the concentrations, obtained after intramuscular ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238704

    authors: Melloni D,Ammatuna P,Formica P,Falletta V,Gaglio F,Cacciatore M,Messina G

    更新日期:1989-01-01 00:00:00

  • Antitumour activity of some platinum compounds.

    abstract::A group of cis-ethylenediammine platinum (II) complexes were synthesized and their activity against Sarcoma-180 ascites tumour cells in mouse was tested. One of the compounds, Pt(HOCH2CH2NHCH2CH2NH2)Cl2, showed significant antitumour activity having little toxicity to the host. Like the parent compound, cis-DDP, it bi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238314

    authors: Chakraborty BK,Biswas N,Choudhury K,Neogy RK,Das Sarma B

    更新日期:1985-01-01 00:00:00

  • Pharmacokinetics of Benzylpenicillin (Penicillin G) during Prolonged Intermittent Renal Replacement Therapy.

    abstract::Prolonged intermittent renal replacement therapy (PIRRT) is an increasingly adopted method of renal replacement in critically ill patients. Like continuous renal replacement therapy, PIRRT can alter the pharmacokinetics (PK) of many drugs. In this setting, dosing data for antibiotics like benzylpenicillin are lacking....

    journal_title:Chemotherapy

    pub_type:

    doi:10.1159/000499375

    authors: Cheng V,Rawlins M,Chang T,Fox E,Dyer J,Allen C,Litton E,Page MM,Hoad K,Roberts JA

    更新日期:2019-01-01 00:00:00

  • Studies on the mode of action of 5-fluorocytosine in Aspergillus species.

    abstract::The mode of action of 5-fluorocytosine (5-FC) was studied in three isolates of pathogenic Aspergillus with varying degrees of susceptibility to the drug. Distribution studies showed that susceptibility or resistance to 5-FC was not dependent on uptake of the drug. While only a small percentage of the total 5-FC taken ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237824

    authors: Wagner GE,Shadomy S

    更新日期:1979-01-01 00:00:00

  • Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.

    abstract::The antibacterial activity of tobramycin, gentamicin, erythromycin, cloxacillin, kanamycin, cephalexin, penicillin, carbenicillin and polymyxin were compared against 303 clinical bacterial isolates from a pediatric hospital patient population. Standard disk diffusion and agar-dilution methods were employed. Significan...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000221851

    authors: Laxer RM,Mackay E,Marks MI

    更新日期:1975-01-01 00:00:00

  • Antiandrogen and antineoplastic effects of a novel drug, CPC10997.

    abstract::CPC10997 was found to be effective in vitro as an antiandrogen without effects on either the estrogen or the progesterone receptors in carcinomas of the breast, ovary and prostate as well as in malignant melanomas. Using the clonogenic assay of Salmon et al. [Cancer Treat. Rep. 65: 1-12, 1981], CPC10997 was found to b...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238360

    authors: Ford LC,Kasha W,Chang NH,DeLange RJ

    更新日期:1985-01-01 00:00:00

  • Effect of L- and D-lysine on the growth of Ehrlich ascites tumour.

    abstract::Contrary to L-lysine, D-lysine showed no inhibitory effect on growth of Ehrlich ascites tumour cell in in vivo studies. The in vitro studies on the growth of cultured Ehrlich ascites tumour cells showed similar results, namely, the growth of tumour cells was inhibited when cultured in 0.02 or 0.03 M L-lysine; while 0....

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238657

    authors: Choy YM,Fung KP

    更新日期:1989-01-01 00:00:00

  • Bioactivity of flurithromycin and other macrolides against intracellular susceptible staphylococci.

    abstract::The intracellular activity of flurithromycin, erythromycin, roxithromycin and miocamycin against susceptible clinical isolates of Staphylococcus aureus, phagocytosed by human monocytes, was investigated. Intracellular bioactivity was studied in a 24-hour assay, using experimental conditions which allowed the intracell...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238973

    authors: Fietta A,Boeri P,Colombo ML,Merlini C,Gialdroni Grassi G

    更新日期:1993-01-01 00:00:00

  • In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase.

    abstract::The in vitro activity of cefetamet against Escherichia coli, Klebsiella pneumoniae and Serratia marcescens strains expressing an SHV-5-type beta-lactamase was evaluated. Most of the examined strains were susceptible to the antibiotic. Cefetamet was found to be considerably more active than ceftazidime and aztreonam. I...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239462

    authors: Tzouvelekis LS,Prinarakis EE,Gazouli M,Miriagou V,Tzelepi E,Legakis NJ

    更新日期:1996-09-01 00:00:00

  • Ceftazidime: in vitro comparison with cephalothin, cefuroxime, and netilmicin. A Norwegian study.

    abstract::The in vitro activity of ceftazidime has been compared with those of cephalothin, cefuroxime, and netilmicin against a variety of gram-positive and gram-negative bacteria in order to register sensitivity patterns in the western part of Norway. An agar dilution method was used for minimal inhibitory concentration (MIC)...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238256

    authors: Digranes A,Dibb WL,Benonisen E

    更新日期:1984-01-01 00:00:00

  • A retrospective study of the novel combination of paclitaxel and S1 for pretreated advanced non-small cell lung cancer.

    abstract:BACKGROUND:Recently, multiple-line chemotherapy has become popular for non-small cell lung cancer (NSCLC). The survival time of patients is influenced by patient characteristics and subsequent treatments. METHODS:The usefulness of paclitaxel plus S1 (PTX+S1) was evaluated in 46 pretreated NSCLC patients. Time from the...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000345624

    authors: Aono N,Ito Y,Nishino K,Uchida J,Kumagai T,Akazawa Y,Okuyama T,Yoshinami T,Imamura F

    更新日期:2012-01-01 00:00:00

  • Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. IV. N-formimidoyl thienamycin.

    abstract::Minimal bactericidal concentrations of thienamycin revealed moderate intraphagolysosomal bactericidal activity against pseudo-(PSR) and genuinely serum-resistant (NSS) assay strains of Serratia marcescens. Combinations of inhibitory and subinhibitory concentrations of thienamycin with 55 vol% of defibrinated human blo...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238185

    authors: Traub WH

    更新日期:1983-01-01 00:00:00